Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 7, 2010, Pages 919-923

  Guenova, E ^a,b   Volz, T ^a   Eichner, M ^a   Hoetzenecker, W ^a   Caroli, U ^a   Griesinger, G ^a   Burow, G ^c   Mitev, V ^b   Biedermann, T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c Thermo Fisher Scientific   (United States)

Author keywords

Age; Anaphylactic reaction; Hymenoptera venom; Severity; Tryptase

Indexed keywords

TRYPTASE; WASP VENOM; ARTHROPOD VENOM; IMMUNOGLOBULIN E;

ADULT; AGED; ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; CONCENTRATION (PARAMETERS); DERMATOLOGY; DISEASE SEVERITY; FEMALE; GERIATRICS; GERMANY; HONEYBEE; HUMAN; HYMENOPTERA; INSECT STING; MAJOR CLINICAL STUDY; MALE; MAST CELL; MASTOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; WASP; ADOLESCENT; AGE; ANIMAL; BLOOD; ENZYMOLOGY; IMMUNOLOGY; INSECT BITE; MIDDLE AGED; SKIN TEST;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANAPHYLAXIS; ANIMALS; ARTHROPOD VENOMS; FEMALE; HUMANS; HYMENOPTERA; IMMUNOGLOBULIN E; INSECT BITES AND STINGS; MALE; MIDDLE AGED; RISK FACTORS; SKIN TESTS; TRYPTASES;

EID: 77953104572     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02302.x     Document Type: Article

References (26)

1. Muller U, Mosbech H. Position paper: immunotherapy with hymenoptera venoms. (EAACI) The European Academy of Allergology and Clinical Immunology. Allergy 1993 48 : 37 46.
2. Clark S, Camargo CA Jr. Epidemiology of anaphylaxis. Immunol Allergy Clin North Am 2007 27 : 145 163. v.
3. Bilo BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol 2008 8 : 330 337.
4. Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003 33 : 1216 1220.
5. Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001 357 : 361 362.
6. Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007 7 : 337 341.
7. Biedermann T, Rueff F, Sander CA, Przybilla B. Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels. Br J Dermatol 1999 141 : 1110 1112.
8. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008 63 : 226 232.
9. Schwartz LB, Sakai K, Bradford TR, Ren SL, Zweiman B, Worobec AS et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995 96 : 2702 2710.
10. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989 83 : 1551 1555.
11. Kucharewicz I, Bodzenta-Lukaszyk A, Szymanski W, Mroczko B, Szmitkowski M. Basal serum tryptase level correlates with severity of hymenoptera sting and age. J Investig Allergol Clin Immunol 2007 17 : 65 69.
12. Lockey RF, Turkeltaub PC, Baird-Warren IA, Olive CA, Olive ES, Peppe BC et al. The Hymenoptera venom study I, 1979-1982: demographics and history-sting data. J Allergy Clin Immunol 1988 82 (3 Pt 1 370 381.
13. Lantner R, Reisman RE. Clinical and immunologic features and subsequent course of patients with severe insect-sting anaphylaxis. J Allergy Clin Immunol 1989 84 (6 Pt 1 900 906.
14. Przybilla B, Ring J, Grieshammer B. Association of features of atopy and diagnostic parameters in hymenoptera venom allergy. Allergy 1991 46 : 570 576.
15. Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res 1966 3 : 331 333.
16. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009 114 : 937 951. Epub 2009 Apr 8.
17. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002 100 : 2292 2302.
18. Dugas-Breit S, Przybilla B, Schopf P, Rueff F. Possible circadian variation of serum mast cell tryptase concentration. Allergy 2005 60 : 689 692.
19. Schwartz LB. Tryptase: a clinical indicator of mast cell-dependent events. Allergy Proc 1994 15 : 119 123.
20. Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Vanderzwan JK et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 1994 14 : 190 204.
21. Van der Linden PWG, Hack CE, Poortman J, Viviekipp YC, Struyvenberg A, Vanderzwan JK. Insect-sting challenge in 138 patients-relation between clinical severity of anaphylaxis and mast-cell activation. J Allergy Clin Immunol 1992 90 : 110 118.
22. Sturm G, Wiednig M, Strele A, Schuster C, Aberrer W. Baseline serum tryptase levels and the severity of sting reactions in Hymenoptera venom allergy. Abstract book of the XXV Congress of EAACI.
23. Sagher F, Even-Paz Z. Mastocytosis and the mast cell.
24. Ispas L, Henriksen RA, Metzger WJ. The many faces of systemic mastocytosis. Ann Allergy Asthma Immunol 2001 87 : 6 14.
25. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 2006 26 : 451 463.
26. Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005 60 : 1459 1470.